To eat like royalty, sometimes you have to spend like it. That idea certainly applies in the case of king salmon, which will ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...